Variable frequencies of peripheral T-lymphocyte subsets in the diabetes spectrum from type 1 diabetes through latent autoimmune diabetes in adults (LADA) to type 2 diabetes.
Variable frequencies of peripheral T-lymphocyte subsets in the diabetes spectrum from type 1 diabetes through latent autoimmune diabetes in adults (LADA) to type 2 diabetes.
复制标题
DOI:
10.3389/fimmu.2022.974864
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
Zhou, Zhiguang
中科院分区:
文献类型:
--
作者:
Tan, Tingting;Xiang, Yufei;Deng, Chao;Cao, Chuqing;Ren, Zhihui;Huang, Gan;Zhou, Zhiguang
T lymphocytes are key players in the pathogenesis of autoimmune diabetes. We recruited subjects with T1D (n=81), LADA (n=82), T2D (n=95) and NGT (n=218) and analyzed the percentages of T-lymphocyte subsets, including T helper 1 (Th1), T helper 2 (Th2), T helper 17 (Th17), T cytotoxic 1 (Tc1), regulatory T cells (Tregs), effector T (Teff), naïve T, central memory T (Tcm), and effector memory T (Tem) cells by flow cytometry. LADA patients possessed similar frequencies of IFN-γ+CD4+ T (Th1), IFN-γ+CD8+ T and CD4+ Teff cells compared with T1D patients, but much lower than those of NGT subjects. Like T2D patients, LADA patients had increased frequencies of CD4+ Tem and CD8+ Tem cells with respect to T1D and NGT subjects. In LADA patients, Th2 cells were decreased while CD4+ Tcm cells were increased compared with NGT subjects. Notably, we observed significant negative correlations between the CD4+ Tcm cell frequency and C-peptide in LADA subjects. These data demonstrates that LADA patients possess T-cell subset changes resembling both T1D and T2D and represent the middle of the diabetes spectrum between T1D and T2D. Based on these T-cell subset alterations, we speculate that autoimmunity-induced β-cell destruction and inflammation-induced insulin resistance might both be involved in the pathogenesis of LADA.
登录
查看更多内容
DOI:
10.4049/jimmunol.1002615
发表时间:
2011-01-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Jagannathan-Bogdan M;McDonnell ME;Shin H;Rehman Q;Hasturk H;Apovian CM;Nikolajczyk BS
通讯作者:
Nikolajczyk BS
影响因子:
16.2
作者:
Brooks-Worrell BM;Reichow JL;Goel A;Ismail H;Palmer JP
通讯作者:
Palmer JP
影响因子:
3.8
作者:
Liang, Huiying;Cheng, Ying;Zhou, Zhiguang
通讯作者:
Zhou, Zhiguang
DOI:
10.1002/oby.21243
发表时间:
2016-01
期刊:
Obesity (Silver Spring, Md.)
影响因子:
--
作者:
Ip B;Cilfone NA;Belkina AC;DeFuria J;Jagannathan-Bogdan M;Zhu M;Kuchibhatla R;McDonnell ME;Xiao Q;Kepler TB;Apovian CM;Lauffenburger DA;Nikolajczyk BS
通讯作者:
Nikolajczyk BS
影响因子:
7.7
作者:
Orban T;Beam CA;Xu P;Moore K;Jiang Q;Deng J;Muller S;Gottlieb P;Spain L;Peakman M;Type 1 Diabetes TrialNet Abatacept Study Group
通讯作者:
Type 1 Diabetes TrialNet Abatacept Study Group